Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

Piedmont Heart Institute

A. Klein

Medical Management of Peripheral Arterial Disease

NY Endovascular Summit

H. Kamran

Perioperative Management of Antithrombotic Therapy

CHEST 2022 Coverage

J. Douketis

Why Every Physician Must Diagnose Peripheral Artery Disease? How Can…

American Heart & Vascular Institute

S. Khan

Risk Factors and Medical Management of PAD

Jefferson Health

T. Galanis

PAD and Endovascular Intervention

Complex Coronary Cases

V. Kapur

Clot Chronicles: Peripheral Artery Disease — What Clinicians Should …

The North American Thrombosis Forum (NATF)

M. Mcdermott

Anti Platelet Therapy Clinical Case Discussion: Q&A with Dr. Neal Kl…

Houston Methodist DeBakey Heart and Vascular Center

N. Kleiman

Anti-platelets in Primary and Secondary Prevention

1st Annual Heart of Prevention Symposium

C. Kliger

Medical Management of PAD: Current Data and Recommendations

NY Endovascular Summit

J. Olin

Update on Antiplatelet and Antithrombotic Use in Atherosclerosis

NY Endovascular Summit

R. Mehran, A. Lee, P. Krishnan

Femoropopliteal Artery Disease and Treatment Options / Literature Re…

NY Endovascular Summit

S. Parikh

Maximal Medical Therapy in Peripheral Arterial Disease

NY Endovascular Summit

D. Kadian-Dodov

ESC 2024 Insights: Apixaban vs Clopidogrel on a Background of Aspiri…

ESC 2024 Insights

Prevention, Protection and Plumbing Key for PAD

Piedmont Heart Institute Napa Valley Cardiology Conference

A. Klein

Treating Peripheral Artery Disease: Beyond Intervention

NY Endovascular Summit

J. Olin

Peripheral Artery Disease: Hard to Detect and Treat

Houston Methodist DeBakey Heart and Vascular Center

J. P. Cooke

Peripheral Arterial Disease: Prevalence, Incidence and Associated Ri…

NY Endovascular Summit

M. Maloy

Perioperative Considerations for Anticoagulation With Mechanical Dev…

James Douketis